Fund Holdings — Novo Holdings A/S

Total Portfolio Value:
$2.01B
Total Bought:
$79.97M
Total Sold:
$162.75M
Net Transaction:
-$82.77M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Vanguard Index FdsTotal Stock Market1,038,5501,038,5500$277.82M$294.08M14.61%+$16.25M
Tempus AI, Inc.CL A(TEM)4,074,4194,074,4190$142.60M$230.61M11.45%+$88.01M
Brookfield CorporationCL A(BN)3,880,2303,491,230-389,000$161.18M$185.56M9.22%+$24.37M
Edgewise Therapeutics, Inc.(EWTX)6,344,4305,549,900-794,530$114.26M$148.13M7.36%+$33.86M
Corcept Therapeutics Incorporated(CORT)2,411,3622,411,3620$78.35M$111.60M5.54%+$33.25M
Asml Holding N VN Y REGISTRY SHS
N Y REGISTRY SHS
133,336133,3360$136.37M$111.10M5.52%-$25.26M
Salesforce, Inc.(CRM)480,160368,560-111,600$123.45M$100.88M5.01%-$22.57M
Vaxcyte, Inc.(PCVX)950,000750,000-200,000$71.73M$85.70M4.26%+$13.97M
Mirum Pharmaceuticals, Inc.(MIRM)1,500,0001,500,0000$51.28M$58.50M2.91%+$7.21M
Viridian Therapeutics, Inc.(VRDN)2,000,0002,385,000+385,000$26.02M$54.26M2.69%+$28.24M
Alibaba Group Holding LimitedADS(BABA)500,827500,8270$36.06M$53.15M2.64%+$17.09M
Insmed Incorporated(INSM)800,000724,666-75,334$53.60M$52.90M2.63%-$699.4K
Crinetics Pharmaceuticals In1,000,0001,000,0000$44.79M$51.10M2.54%+$6.31M
Cable One, Inc.(CABO)118,403118,4030$41.91M$41.42M2.06%-$498.5K
ArriVent BioPharma, Inc.(AVBP)1,500,0001,505,315+5,315$27.82M$35.37M1.76%+$7.55M
Merus N V675,000700,000+25,000$39.94M$34.97M1.74%-$4.97M
BioMarin Pharmaceutical Inc.(BMRN)490,000490,0000$40.34M$34.44M1.71%-$5.90M
Celldex Therapeutics, Inc.(CLDX)850,000963,663+113,663$31.46M$32.75M1.63%+$1.30M
Alnylam Pharmaceuticals, Inc.(ALNY)118,383118,3830$28.77M$32.56M1.62%+$3.79M
Pharvaris N V
COM
1,725,0001,725,0000$32.43M$31.95M1.59%-$483.0K
LanzaTech Global, Inc.(LNZA)15,814,84515,814,8450$29.26M$30.21M1.50%+$948.9K
Brookfield Asset Management Ltd.CL A(BAM)627,207627,2070$23.87M$29.66M1.47%+$5.80M
Cargo Therapeutics Inc1,544,0001,544,0000$25.35M$28.49M1.41%+$3.13M
Amicus Therapeutics Inc
COM
2,500,0002,500,0000$24.80M$26.70M1.33%+$1.90M
Rocket Pharmaceuticals, Inc.(RCKT)1,100,0001,100,0000$23.68M$20.32M1.01%-$3.37M
Zenas BioPharma, Inc.(ZBIO)01,150,000+1,150,000$0$19.46M0.97%+$19.46M
4d Molecular Therapeutics In1,400,0001,500,000+100,000$29.39M$16.21M0.81%-$13.17M
Blueprint Medicines Corp175,000175,0000$18.86M$16.19M0.80%-$2.67M
Verve Therapeutics Inc2,400,0002,400,0000$11.71M$11.62M0.58%-$96.0K
Lexeo Therapeutics, Inc.(LXEO)1,450,5001,122,581-327,919$23.27M$10.15M0.50%-$13.12M
Kyverna Therapeutics, Inc.(KYTX)1,750,0001,850,000+100,000$13.13M$9.05M0.45%-$4.08M
Metagenomi Therapeutics, Inc.(MGX)1,800,0001,800,0000$7.34M$3.91M0.19%-$3.44M
Io Biotech Inc4,429,4493,354,449-1,075,000$5.18M$3.52M0.17%-$1.66M
AbCellera Biologics Inc.(ABCL)1,126,9151,126,9150$3.34M$2.93M0.15%-$405.7K
Marqeta, Inc.CL A(MQ)441,558441,5580$2.42M$2.17M0.11%-$247.3K
Damora Therapeutics, Inc.(DMRA)099,913+99,913$0$1.21M0.06%+$1.21M
Spero Therapeutics, Inc.(SPRO)468,902468,9020$609.6K$628.3K0.03%+$18.8K
Apple Inc.(AAPL)182,9600-182,960$38.54M$0—-$38.54M
Galecto Inc2,497,7910-2,497,791$1.18M$0—-$1.18M
Morphic Hldg Inc375,0000-375,000$12.78M$0—-$12.78M
Page 1 of 1
Novo Holdings A/S — 13F Holdings — Q3 2024 | TickerTrail